Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE -- Ignore unavailable to you. Want to Upgrade?

To: Mark Adams who wrote (187)	4/11/1999 9:31:00 AM
From: SemiBull	Read Replies (2) \| Respond to of 415

Mark, <But the burn rate will go up if they start clinical trials, unless they find a partner with deep pockets.> Can you think of any prospects? < I think we are waiting for them to bring selected products to trial. Which I hope happens sooner rather than later.> Which selected products do you foresee coming to trial initially? Any guess as to when in view of their burn rate? Maybe I'll call their IR this week if i get the chance and report back....would be nice to awaken this thread a little. :~) Thanks in advance....SemiBull